AONC (American Oncology Network) EBIT: $-18 Mil (TTM As of Dec. 2024)


AONC American Oncology Network Inc AONC
20 GF Score
Price $10.00
View Full Analysis

What is American Oncology Network EBIT?

American Oncology Network AONC 20 EBIT is $-18 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

American Oncology Network's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was $4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was $-18 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. American Oncology Network's annualized ROC % for the quarter that ended in Dec. 2024 was 15.35%. American Oncology Network's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 16.54%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. American Oncology Network's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -4.06%.

American Oncology Network  (OTCPK:AONC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

American Oncology Network's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=33.38 * ( 1 - 0% )/( (212.906 + 221.981)/ 2 )
=33.38/217.4435
=15.35 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=394.811 - 162.473 - ( 19.432 - max(0, 199.857 - 271.23+19.432))
=212.906

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=470.328 - 175.707 - ( 72.64 - max(0, 216.847 - 331.472+72.64))
=221.981

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

American Oncology Network's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=15.68/( ( (91.015 + max(-0.80399999999997, 0)) + (98.531 + max(-6.182, 0)) )/ 2 )
=15.68/( ( 91.015 + 98.531 )/ 2 )
=15.68/94.773
=16.54 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(128.011 + 49.266 + 9.388) - (162.473 + 0 + 24.996)
=-0.80399999999997

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(129.233 + 60.712 + 8.494) - (175.707 + 0 + 28.914)
=-6.182

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

American Oncology Network's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-17.556/432.197
=-4.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network EBIT Related Terms

American Oncology Network EBIT Historical Data

* Premium members only.

The historical data trend for American Oncology Network's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network EBIT Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
22.28 1.77 6.01 -56.09 -17.56

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -20.36 -20.35 -1.44 0.31 3.92

AONC vs TOI, AUNA, AGL: EBIT Comparison

For the Medical Care Facilities subindustry, American Oncology Network's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Oncology Network EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where American Oncology Network's EV-to-EBIT falls into.


AONC
20GF Score
American Oncology Network Inc AONC
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-18 Mil mean?
American Oncology Network (AONC) has a EBIT of $-18 Mil as of Dec. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on American Oncology Network.
Is American Oncology Network's EBIT too high?
American Oncology Network's current EBIT is $-18 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's EBIT compare to TOI and AUNA?
American Oncology Network's EBIT of $-18 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on American Oncology Network. American Oncology Network's current EBIT is $-18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current EBIT of $-18 Mil. The current EBIT is $-18 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For American Oncology Network (AONC), the current EBIT is $-18 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price